Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03466372 · ClinicalTrials.gov registry record · NA
Innovative Gait Biofeedback Strategies for Stroke Rehabilitation
A NA study of Stroke, Cardiovascular and Gait, Hemiplegic, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03466372: Completed NA study of Stroke, Cardiovascular and Gait, Hemiplegic, sponsored by Emory University.
NCT03466372 is a NA study of Stroke, Cardiovascular and Gait, Hemiplegic that has completed, run by Emory University. The registered enrollment target is 20 participants, below the 61-participant average among 4 other Stroke, Cardiovascular trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03466372, a NA study of Stroke, Cardiovascular and Gait, Hemiplegic, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The long-term study goal is to develop a more engaging, motivating gait biofeedback methodologies specifically designed for post-stroke gait training. The current project aims to address fundamental questions regarding the optimal methodology to deliver AGRF biofeedback during gait, and the feasibility and preliminary efficacy of AGRF progression protocols for improved gait patterns and gait function. The study objectives are to (1) evaluate the immediate effects of biofeedback training methodology on gait biomechanics; and (2) evaluate the feasibility and short-term effects on gait performance of a real-time biofeedback protocol incorporating progression criteria (similar to those employed during clinical rehabilitative training).
Primary Outcome
peak GRF generated by the leg affected by the stroke
Conditions Studied
Interventions
- BEHAVIORAL biofeedback
Study Locations (1)
Georgia
- Emory Univeristy - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-03-22 |
| Est. Completion | 2018-10-03 |
| Phase | NA |
What the finished NCT03466372 record still lists
NCT03466372 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 61-participant average among 4 other Stroke, Cardiovascular trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with Stroke, Cardiovascular appearing as the primary indexed condition, and to 1 intervention - of which biofeedback is the first listed.
NCT03466372 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT03466372 about?
NCT03466372 is a clinical study titled "Innovative Gait Biofeedback Strategies for Stroke Rehabilitation". The long-term study goal is to develop a more engaging, motivating gait biofeedback methodologies specifically designed for post-stroke gait training. The current project aims to address fundamental questions regarding the optimal methodology to deliver AGRF biofeedback during gait, and the feasibil...
What is the current status of trial NCT03466372?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-03-22. Estimated completion is 2018-10-03.
What conditions does trial NCT03466372 study?
This clinical trial studies the following conditions: Stroke, Cardiovascular, Gait, Hemiplegic.
What interventions are being tested in trial NCT03466372?
The interventions under investigation include: biofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT03466372?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03466372 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Cardiovascular
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Implementation of IVS3 for Upper Limb Motor Recovery
RECRUITING · NA
-
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
RECRUITING · NA
-
Ischemic Conditioning Improves Walking Function Post Stroke
RECRUITING · NA
-
Advanced Cardiac Imaging To Predict Embolic Stroke On Brain MRI: A Pilot Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI